The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
TGF-β-induced epithelial to mesenchymal transition
Open accessAbstract
During development and in the context of different morphogenetic events, epithelial cells undergo a process called epithelial to mesenchymal transition or transdifferentiation (EMT). In this process, the cells lose their epithelial characteristics, including their polarity and specialized cell-cell contacts, and acquire a migratory behavior, allowing them to move away from their epithelial cell community and to integrate into surrounding tissue, even at remote locations. EMT illustrates the differentiation plasticity during development and is complemented by another process, called mesenchymal to epithelial transition (MET). While being an integral process during development, EMT is also recapitulated under pathological conditions, prominently in fibrosis and in invasion and metastasis of carcinomas. Accordingly, EMT is considered as an important step in tumor progression. TGF-beta signaling has been shown to play an important role in EMT. In fact, adding TGF-beta to epithelial cells in culture is a convenient way to induce EMT in various epithelial cells. Although much less characterized, epithelial plasticity can also be regulated by TGF-beta-related bone morphogenetic proteins (BMPs), and BMPs have been shown to induce EMT or MET depending on the developmental context. In this review, we will discuss the induction of EMT in response to TGF-beta, and focus on the underlying signaling and transcription mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“EMT plays an important role in cancer progression and is induced by TGFβ [23].”
The cited source says what the claim attributes to it.
In the citing paper
“Adding TGF-β induces EMT in diverse epithelial cell cultures via the SMAD signaling pathway (56).”
From Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis (2021) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Han, S., Ritzenthaler, J. D., Sitaraman, S. V., & Roman, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604013200 · Cited by 98
RetractedSmad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,498
Self-citationTwist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R., Côme, C., Savagner, P., Gitelman, I., Richardson, A. L., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,917
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew‐Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,852
Cano, A., Pérez‐Moreno, M., Rodrigo, I., Locascio, A., Blanco, M. J., Barrio, M. G. D., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,672
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121
Batlle, E., Sancho, E., Francı́, C., Dominguez-Sola, D., Monfar, M., Baulida, J., & de Herreros, A. G. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,671
Multifunctional strands in tight junctions
Tsukita, S., Furuse, M., & Itoh, M. (2001) · Nature reviews. Molecular cell biology · doi:10.1038/35067088 · Cited by 2,578
Convergence of Wnt, ß-Catenin, and Cadherin Pathways
Nelson, W. J., & Nusse, R. (2004) · Science · doi:10.1126/science.1094291 · Cited by 2,537
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Self-citation
Research works printed but not linked: 1
- Akhurst R . TGF-β signaling in epithelial-mesenchymal transition and invasion and metastasis. In: Derynck R, Miyazono K, eds. The TGF-beta family. Cold Spring Harbor Laboratory Press: New York 2007:939–964.
Cited by
Sorted by citations
Items 201–300 of 1,008
Role of Epithelial to Mesenchymal Transition in Colorectal Cancer
Lu, J., Kornmann, M., & Traub, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914815 · Cited by 156
Transglutaminase 2: A multi-tasking protein in the complex circuitry of inflammation and cancer
Mehta, K., Kumar, A., & Kim, H. I. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.029 · Cited by 151
Wu, J., Ru, N.-Y., Zhang, Y., Li, Y., Wei, D., Ren, Z., Huang, X.-F., Chen, Z.-N., & Bian, H. (2011) · Oncogene · doi:10.1038/onc.2011.149 · Cited by 147
Deng, X., Wu, B., Ke, X., Kang, J., Xie, J., Zhang, X., & Fan, Y. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000369676 · Cited by 146
Makrodouli, E., Oikonomou, E., Koc, M., Anděra, L., Sasazuki, T., Shirasawa, S., & Pintzas, A. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-118 · Cited by 154
EMT and Treatment Resistance in Pancreatic Cancer
Gaianigo, N., Melisi, D., & Carbone, C. (2017) · Cancers · doi:10.3390/cancers9090122 · Cited by 149
Induction of epithelial–mesenchymal transition by transforming growth factor β
Moustakas, A., & Heldin, C. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.04.002 · Cited by 145
Brase, J. C., Johannes, M., Mannsperger, H., Fälth, M., Metzger, J., Kacprzyk, L. A., Andrasiuk, T., Gade, S., Meister, M. A., Sirma, H., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-507 · Cited by 144
PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer
Avasarala, S., Scoyk, M. M. V., Rathinam, M. K. K., Zerayesus, S., Zhao, X., Zhang, W., Pergande, M. R., Borgia, J. A., DeGregori, J. V., Port, J. D., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.636050 · Cited by 144
Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis
Strippoli, R., Moreno-Vicente, R., Battistelli, C., Cicchini, C., Noce, V., Amicone, L., Marchetti, A., del Pozo, M. Á., & Tripodi, M. (2016) · Stem Cells International · doi:10.1155/2016/3543678 · Cited by 144
Cancer-associated fibroblasts: how do they contribute to metastasis?
Kwa, M. Q., Herum, K. M., & Brakebusch, C. (2019) · Clinical & Experimental Metastasis · doi:10.1007/s10585-019-09959-0 · Cited by 150
TGF-β in cancer and bone: Implications for treatment of bone metastases
Juárez, P., & Guise, T. A. (2010) · Bone · doi:10.1016/j.bone.2010.08.004 · Cited by 153
Sánchez‐Duffhues, G., de Vinuesa, A. G., & ten Dijke, P. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24589 · Cited by 145
The network of epithelial–mesenchymal transition: potential new targets for tumor resistance
Nantajit, D., Lin, D., & Li, J. J. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1840-y · Cited by 143
TACE-Mediated Ectodomain Shedding of the Type I TGF-β Receptor Downregulates TGF-β Signaling
Liu, C., Xu, P., Lamouille, S., Xu, J., & Derynck, R. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.018 · Cited by 145
Self-citationTGF-β Targets the Hippo Pathway Scaffold RASSF1A to Facilitate YAP/SMAD2 Nuclear Translocation
Pefani, D., Paňková, D., Abraham, A., Grawenda, A. M., Vlahov, N., Scrace, S., & Neill, E. O. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.05.012 · Cited by 145
Dongre, A., Rashidian, M., Eaton, E. N., Reinhardt, F., Thiru, P., Zagorulya, M., Nepal, S., Banaz, T., Martner, A., Spranger, S., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0603 · Cited by 146
Myles, I. A., Castillo, C. R., Barbian, K. D., Kanakabandi, K., Virtaneva, K., Fitzmeyer, E., Paneru, M., Otaizo-Carrasquero, F., Myers, T. G., Markowitz, T. E., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz8631 · Cited by 139
Chang, Y., Tsai, C., Lai, Y., Yu, C., Chi, W., Li, J. J., & Chang, W. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12219 · Cited by 137
TRB3 interacts with SMAD3 promoting tumor cell migration and invasion
Hua, F., Mu, R., Liu, J., Xue, J., Wang, Z., Lin, H., Yang, H., Chen, X., & Hu, Z. (2011) · Journal of Cell Science · doi:10.1242/jcs.082875 · Cited by 141
Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors
Sun, J., Zhang, D., Bae, D.-H., Sahni, S., Jansson, P. J., Zheng, Y., Zhao, Q., Yue, F., Zheng, M., Kovačević, Ž., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt163 · Cited by 140
Cruz-Solbes, A. S., & Youker, K. A. (2017) · Results and problems in cell differentiation · doi:10.1007/978-3-319-51436-9_13 · Cited by 139
Hypoxia-Induced Secretion of TGF-β1 in Mesenchymal Stem Cell Promotes Breast Cancer Cell Progression
Hung, S.-P., Yang, M.-H., Tseng, K.-F., & Lee, O. K. (2013) · Cell Transplantation · doi:10.3727/096368912x657954 · Cited by 137
Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target
Qian, W., Zhao, M., Wang, R., & Li, H. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01161-8 · Cited by 139
The functions of microRNAs in pluripotency and reprogramming
Leonardo, T. R., Schultheisz, H. L., Loring, J. F., & Laurent, L. C. (2012) · Nature Cell Biology · doi:10.1038/ncb2613 · Cited by 138
Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling
Junk, D. J., Bryson, B. L., Smigiel, J. M., Parameswaran, N., Bartel, C. A., & Jackson, M. W. (2017) · Oncogene · doi:10.1038/onc.2017.33 · Cited by 133
Stephens, R., Lim, K., Portela, M., Kvansakul, M., Humbert, P. O., & Richardson, H. E. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.01.011 · Cited by 132
Boudreau, H. E., Emerson, S. U., Korzeniowska, A., Jendrysik, M. A., & Leto, T. L. (2009) · Journal of Virology · doi:10.1128/jvi.01059-09 · Cited by 132
Xiang, Y., Zhang, Y., Tang, Y., & Li, Q. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477479 · Cited by 132
FGF-1 reverts epithelial-mesenchymal transition induced by TGF-β1 through MAPK/ERK kinase pathway
Ramos, C., Becerril, C., Montaño, M., de Alba, C. G., Ramı́rez, R., Checa, M., Pardo, A., & Selman, M. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00070.2010 · Cited by 131
Biomechanics of TGFβ‐induced epithelial‐mesenchymal transition: implications for fibrosis and cancer
O’Connor, J. W., & Gomez, E. W. (2014) · Clinical and Translational Medicine · doi:10.1186/2001-1326-3-23 · Cited by 136
Title, A. C., Hong, S., Pires, N. D., Hasenöhrl, L., Godbersen, S., Stokar‐Regenscheit, N., Bartel, D. P., & Stoffel, M. (2018) · Nature Communications · doi:10.1038/s41467-018-07130-z · Cited by 136
Partial EMT in head and neck cancer biology: a spectrum instead of a switch
Pal, A., Barrett, T. F., Paolini, R. L., Parikh, A. S., & Puram, S. V. (2021) · Oncogene · doi:10.1038/s41388-021-01868-5 · Cited by 131
Vendrell, J. A., Thollet, A., Nguyen, N. T., Ghayad, S. E., Vinot, S., Bièche, I., Grisard, E., Josserand, V., Coll, J., Roux, P., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3095 · Cited by 131
Chen, X., Zhang, H., Wang, H.-B., Zhu, J., Zhou, W.-Y., Zhang, H., Zhao, M.-C., Su, J.-M., Gao, W., Zhang, L., et al. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1128-0 · Cited by 131
Fate-determining mechanisms in epithelial–myofibroblast transition: major inhibitory role for Smad3
Masszi, A., Speight, P., Charbonney, E., Lodyga, M., Nakano, H., Szászi, K., & Kapùs, A. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.200906155 · Cited by 130
TGF‑β signaling: A complex role in tumorigenesis (Review)
Liu, S., Chen, S., & Zeng, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7970 · Cited by 132
Liu, P., Zhang, B., Chen, Z., He, Y., Du, Y., Liu, Y., & Chen, X. (2020) · Aging · doi:10.18632/aging.102950 · Cited by 129
New Approaches on Cancer ImmunotherapyPreprint
Cha, J., Chan, L.-C., Song, M. S., & Hung, M. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036863 · Cited by 130
Zhang, K.-H., Tian, H.-Y., Gao, X., Lei, W.-W., Hu, Y., Wang, D., Pan, X.-C., Yu, M.-L., Xu, G.-J., Zhao, F., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0112 · Cited by 127
Synergistic action of master transcription factors controls epithelial-to-mesenchymal transition
Chang, H., Liu, Y., Xue, M., Liu, H., Du, S., Zhang, L., & Wang, P. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw126 · Cited by 126
The epigenetic landscape of renal cancer
Morris, M. R., & Latif, F. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.168 · Cited by 129
Cell-surface heparan sulfate proteoglycans as multifunctional integrators of signaling in cancer
Hassan, N., Greve, B., Espinoza‐Sánchez, N. A., & Götte, M. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109822 · Cited by 129
MiRNA-mediated EMT and CSCs in cancer chemoresistance
Dong, B., Li, S., Zhu, S., Yi, M., Luo, S., & Wu, K. (2021) · Experimental Hematology and Oncology · doi:10.1186/s40164-021-00206-5 · Cited by 127
The Enhanced Metastatic Potential of Hepatocellular Carcinoma (HCC) Cells with Sorafenib Resistance
Chow, A. K.-M., Ng, L., Lam, C. S.-C., Wong, S. K., Wan, T. M.-H., Cheng, N. S.-M., Yau, T. C. C., Poon, R. T. P., & Pang, R. W. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078675 · Cited by 125
Kumar, A., Xu, J., Brady, S. W., Gao, H., Yu, D., Reuben, J. M., & Mehta, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013390 · Cited by 125
Self-citationInflammation and cancer stem cells
Shigdar, S. L., Li, Y., Bhattacharya, S., O’Connor, M., Pu, C., Lin, J., Wang, T., Xiang, D., Kong, L., Wei, M. Q., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.031 · Cited by 126
Izumchenko, E., Chang, X., Michailidi, C., Kagohara, L. T., Ravi, R. K., Paz, K., Brait, M., Hoque, M. O., Ling, S., Bedi, A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0110 · Cited by 124
Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells
Schwab, A., Siddiqui, A., Vazakidou, M. E., Napoli, F., Böttcher, M., Menchicchi, B., Raza, U., Saatci, Ö., Krebs, A. M., Ferrazzi, F., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2834 · Cited by 128
Interstitial flow promotes macrophage polarization toward an M2 phenotype
Li, R., Serrano, J. C., Xing, H., Lee, T. A., Azizgolshani, H., Zaman, M. H., & Kamm, R. D. (2018) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-03-0164 · Cited by 128
Cell Extrusion: A Stress-Responsive Force for Good or Evil in Epithelial Homeostasis
Ohsawa, S., Vaughen, J. P., & Igaki, T. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.01.009 · Cited by 124
Yu, D., Pan, M., Li, Y., Lu, T., Wang, Z., Liu, C., & Hu, G. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02212-1 · Cited by 123
Johnson, J. R., Roos, A. B., Berg, T., Nord, M., & Fuxe, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016175 · Cited by 123
Zhang, W., Bouchard, G., Yu, A., Shafiq, M., Jamali, M., Shrager, J. B., Ayers, K., Bakr, S. H., Gentles, A. J., Diehn, M., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2928 · Cited by 124
The Epigenetic Regulation of HCC Metastasis
Han, T., Ban, H. S., Hur, K., & Cho, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123978 · Cited by 121
Sun, L., Dong, H., Zhang, W., Wang, N., Ni, N., Bai, X., & Liu, N. (2020) · DNA and Cell Biology · doi:10.1089/dna.2020.5730 · Cited by 121
Wang, Z. P., Li, Y., & Sarkar, F. H. (2010) · Current Stem Cell Research & Therapy · doi:10.2174/157488810790442813 · Cited by 123
Mechanical Control of Epithelial-to-Mesenchymal Transitions in Development and Cancer
Przybyla, L., Muncie, J. M., & Weaver, V. M. (2016) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-111315-125150 · Cited by 123
Glycosylation as a Main Regulator of Growth and Death Factor Receptors Signaling
Ferreira, I. G., Pucci, M., Venturi, G., Malagolini, N., Chiricolo, M., & Dall’Olio, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020580 · Cited by 120
Xiang, X., Niu, Y., Wang, Z.-H., Ye, L., Peng, W., & Zhou, Q. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.07.006 · Cited by 123
Tsutsumi, S., Saeki, H., Nakashima, Y., Ito, S., Oki, E., Morita, M., Oda, Y., Okano, S., & Maehara, Y. (2017) · Cancer Science · doi:10.1111/cas.13237 · Cited by 122
Huang, L., Desai, R., Conrad, D. N., Leite, N. C., Akshinthala, D., Lim, C. M., González, R. S., Muthuswamy, L. B., Gartner, Z. J., & Muthuswamy, S. K. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.03.022 · Cited by 119
Understanding the Process of Corneal Endothelial Morphological Change In Vitro
Roy, O., Leclerc, V. B., Bourget, J., Thériault, M., & Proulx, S. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-16166 · Cited by 119
Gao (2010) · International Journal of Oncology · doi:10.3892/ijo_00000715 · Cited by 118
Wesseling, M., Sakkers, T. R., de Jager, S. C. A., Pasterkamp, G., & Goumans, M. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.02.006 · Cited by 119
Schwann cell plasticity‐roles in tissue homeostasis, regeneration, and disease
Stierli, S., Imperatore, V., & Lloyd, A. C. (2019) · Glia · doi:10.1002/glia.23643 · Cited by 124
Yang, J., LI, T. Z., XU, G. H., Luo, B., Chen, Y. X., & ZHANG, T. (2013) · Neoplasma · doi:10.4149/neo_2013_048 · Cited by 118
Improved chemotherapy for hepatocellular carcinoma.
Cao, H. L., Phan, H., & Yang, L. (2012) · PubMed · Cited by 116
Jeong, H., Ryu, Y.-J., An, J., Lee, Y., & Kim, A. (2012) · Histopathology · doi:10.1111/j.1365-2559.2012.04195.x · Cited by 116
TGFβ pathway inhibition in the treatment of non-small cell lung cancer
Eser, P. Ö., & Janne, P. A. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.11.004 · Cited by 117
Xu, Q., Li, Y., Gao, X., Kang, K., Williams, J. G., Tong, L., Liu, J., Ji, M. H., Deterding, L. J., Tong, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17818-w · Cited by 116
Role of the epithelial–mesenchymal transition and its effects on embryonic stem cells
Kim, Y.-S., Yi, B.-R., Kim, N., & Choi, K. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.44 · Cited by 120
You, S., Yoo, S., Choi, S., Kim, J., Park, S.-J., Ji, J. D., Kim, T., Kim, K., Cho, C., Hwang, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311239111 · Cited by 116
Fardi, M., Alivand, M. R., Baradaran, B., Hagh, M. F., & Solali, S. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28277 · Cited by 116
Li, S., Zhang, J., Qian, S., Wu, X., Sun, L., Ling, T., Jin, Y., Li, W., Sun, L., Lai, M., et al. (2021) · 癌症:英文版 · doi:10.1002/cac2.12130 · Cited by 114
Molecular mechanisms underpinning sarcomas and implications for current and future therapy
Damerell, V., Pepper, M. S., & Prince, S. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00647-8 · Cited by 120
González-Moreno, Ó., Lecanda, J., Green, J. E., Segura, V., Catena, R., Serrano, D., & Calvo, A. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.11.020 · Cited by 114
Molecular Mechanisms of HBV-Associated Hepatocarcinogenesis
Guerrieri, F., Belloni, L., Pediconi, N., & Levrero, M. (2013) · Seminars in Liver Disease · doi:10.1055/s-0033-1345721 · Cited by 118
Yakavets, I., François, A., Benoit, A., Merlin, J., Bezdetnaya, L., & Vogin, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-78087-7 · Cited by 123
Wang, J., Chen, L., Li, Y., & Guan, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024967 · Cited by 113
Wang, H., Zhang, C., Xu, L., Zang, K., Ning, Z., Jiang, F., Chi, H., Zhu, X., & Meng, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.7935 · Cited by 113
The CDR1as/miR-7/TGFBR2 Axis Modulates EMT in Silica-Induced Pulmonary Fibrosis
Yao, W., Li, Y., Han, L., Ji, X., Pan, H., Liu, Y., Yuan, J., Yan, W., & Ni, C. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy221 · Cited by 112
The molecular basis of mammary gland development and epithelial differentiation
Slepicka, P. F., Somasundara, A. V. H., & dos Santos, C. O. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.09.014 · Cited by 120
Lissa, D., Takahashi, N., Desai, P. A., Manukyan, I., Schultz, C. W., Rajapakse, V. N., Velez, M. J., Mulford, D. A., Roper, N., Nichols, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29517-9 · Cited by 112
Chen, H., Zhu, Y., Chen, S., & Tseng, S. C. G. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2011.201 · Cited by 111
Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer
Arzumanyan, A. L., Friedman, T., Kotei, E., Ng, I. O., Lian, Z., & Feitelson, M. A. (2011) · Oncogene · doi:10.1038/onc.2011.255 · Cited by 114
Kanlaya, R., Khamchun, S., Kapincharanon, C., & Thongboonkerd, V. (2016) · Scientific Reports · doi:10.1038/srep30233 · Cited by 110
Chen, I., Chiang, W., Huang, H.-H., Chen, P., Shen, Y., & Chiang, H. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-254 · Cited by 111
Jakobsen, K. R., Demuth, C., Sørensen, B. S., & Nielsen, A. L. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.04.07 · Cited by 112
EZH2 promotes progression of small cell lung cancer by suppressing the TGF-β-Smad-ASCL1 pathway
Murai, F., Koinuma, D., Shinozaki‐Ushiku, A., Fukayama, M., Miyaozono, K., & Ehata, S. (2015) · Cell Discovery · doi:10.1038/celldisc.2015.26 · Cited by 110
Slabáková, E., Pernicová, Z., Slavíčková, E., Staršíchová, A., Kozubı́k, A., & Souček, K. (2011) · The Prostate · doi:10.1002/pros.21350 · Cited by 109
Noncanonical TGF-β Signaling During Mammary Tumorigenesis
Parvani, J. G., Taylor, M. A., & Schiemann, W. P. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9207-3 · Cited by 112
The regulation of TGF-β/SMAD signaling by protein deubiquitination
Zhang, J., Zhang, X., Xie, F., Zhang, Z., van Dam, H., Zhang, L., & Zhou, F. (2014) · Protein & Cell · doi:10.1007/s13238-014-0058-8 · Cited by 114
Dichotomous roles of TGF-β in human cancer
Huang, J. J., & Blobe, G. C. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160065 · Cited by 112
ZEB 1‐regulated inflammatory phenotype in breast cancer cells
Katsura, A., Tamura, Y., Hokari, S., Harada, M., Morikawa, M., Sakurai, T., Takahashi, K., Mizutani, A., Nishida, J., Yokoyama, Y., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12098 · Cited by 114
TRPV 4 regulates matrix stiffness and TGF β1‐induced epithelial‐mesenchymal transition
Sharma, S., Goswami, R., Zhang, D. X., & Rahaman, S. O. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13972 · Cited by 108
The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System
Romeo, E. L., Caserta, C. A., Rumio, C., & Marcucci, F. (2019) · Cells · doi:10.3390/cells8050460 · Cited by 115
Ko, H., So, Y., Jeon, H., Jeong, M., Choi, H., Ryu, S.-H., Lee, S.-W., Yoon, H., & Choi, K. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.018 · Cited by 108
Kumar, M., Allison, D. F., Baranova, N. N., Wamsley, J. J., Katz, A. J., Bekiranov, S., Jones, D. R., & Mayo, M. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068597 · Cited by 107
Sundqvist, A., Zieba, A., Vasilaki, E., Hidalgo, C. H., Söderberg, O., Koinuma, D., Miyazono, K., Ch, H., Landegren, U. D., ten Dijke, P., et al. (2012) · Oncogene · doi:10.1038/onc.2012.370 · Cited by 111
Metadata
- Authors
- Xu, J., Lamouille, S., & Derynck, R.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Derynck, Rik
- Venue
- Cell Research
- Published
- 2009-01-20
- Volume
- 19
- Issue
- 2
- Pages
- 156-172
- ISSN
- 1001-0602 (ISSN-L)
- 1748-7838
- PMC
- PMC4720263
- OpenAlex
- W1760215417
- Cited by
- 2,804
- References
- 167
- Citations by year
- 2026: 123 · 2025: 178 · 2024: 186 · 2023: 207 · 2022: 252 · 2021: 242 · 2020: 220 · 2019: 174 · 2018: 190 · 2017: 197 · 2016: 162 · 2015: 148 · 2014: 149 · 2013: 111 · 2012: 95
- FWCI
- 6.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL060231)
- National Center for Research Resources (P41RR001614)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- epithelial-mesenchymal transition, TGF-beta signaling, mesenchymal-epithelial transition, epithelial plasticity, bone morphogenetic proteins, cell migration, tumor progression, fibrosis, tumor invasion and metastasis, cell polarity, transcriptional regulation
- MeSH terms
- Epithelial Cells, Mesoderm, Transcription Factors, Signal Transduction, Transforming Growth Factor beta, Bone Morphogenetic Proteins, Smad Proteins, Cell Transdifferentiation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review